Literature DB >> 15759030

Mcl-1 gene promoter insertions do not correlate with disease outcome, stage or VH gene mutation status in chronic lymphocytic leukaemia.

G Tobin, A Skogsberg, U Thunberg, A Laurell, A Aleskog, M Merup, C Sundström, G Roos, K Nilsson, R Rosenquist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 15759030     DOI： 10.1038/sj.leu.2403715

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  5 in total

Review 1.  Genetic alterations in chronic lymphocytic leukaemia.

Authors:  Llorenç Coll-Mulet; Joan Gil
Journal:  Clin Transl Oncol       Date:  2009-04       Impact factor: 3.405

2.  Revisiting the role of MCL1 in tumorigenesis of solid cancer: gene expression correlates with antiproliferative phenotype in breast cancer cells and its functional regulatory variants are associated with reduced cancer susceptibility.

Authors:  Sheng Wang; Yan Jiang; Jin Liu; Yuanyuan Zhao; Chan Xiang; Rong Ma; Haidong Gao; Li Jin; Fuchu He; Haijian Wang
Journal:  Tumour Biol       Date:  2014-05-23

3.  ELK4 neutralization sensitizes glioblastoma to apoptosis through downregulation of the anti-apoptotic protein Mcl-1.

Authors:  Bryan W Day; Brett W Stringer; Mark D Spanevello; Sara Charmsaz; Paul R Jamieson; Kathleen S Ensbey; Jacinta C Carter; Joanne M Cox; Vicky J Ellis; Christopher L Brown; David G Walker; Po L Inglis; Suzanne Allan; Brent A Reynolds; Jason D Lickliter; Andrew W Boyd
Journal:  Neuro Oncol       Date:  2011-08-16       Impact factor: 12.300

4.  MicroRNA-223 is a novel negative regulator of HSP90B1 in CLL.

Authors:  Ana E Rodríguez-Vicente; Dalia Quwaider; Rocío Benito; Irena Misiewicz-Krzeminska; María Hernández-Sánchez; Alfonso García de Coca; Rosa Fisac; José-María Alonso; Carolina Zato; Juan Francisco de Paz; Juan Luis García; Ma Eugenia Sarasquete; José Ángel Hernández; Juan M Corchado; Marcos González; Norma C Gutiérrez; Jesús-María Hernández-Rivas
Journal:  BMC Cancer       Date:  2015-04-08       Impact factor: 4.430

Review 5.  The dark matter of the cancer genome: aberrations in regulatory elements, untranslated regions, splice sites, non-coding RNA and synonymous mutations.

Authors:  Sven Diederichs; Lorenz Bartsch; Julia C Berkmann; Karin Fröse; Jana Heitmann; Caroline Hoppe; Deetje Iggena; Danny Jazmati; Philipp Karschnia; Miriam Linsenmeier; Thomas Maulhardt; Lino Möhrmann; Johannes Morstein; Stella V Paffenholz; Paula Röpenack; Timo Rückert; Ludger Sandig; Maximilian Schell; Anna Steinmann; Gjendine Voss; Jacqueline Wasmuth; Maria E Weinberger; Ramona Wullenkord
Journal:  EMBO Mol Med       Date:  2016-05-02       Impact factor: 12.137
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.